Elphogene Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
Elphogene General Information
Description
Developer of a liquid biopsy technology designed to monitor circulating tumor DNA in cancer patients. The company's technology is based on liquid biopsy in the peripheral blood of patients for monitoring the course and treatment of cancer, enabling healthcare professionals to improve the lives of cancer patients by providing them with more accurate and timely information about their disease.
Contact Information
Website
www.elphogene.czCorporate Office
- Carolina Centrum
- Drnovska 1112/60, Prague 6
- Prague, Ruzyně 161 00
- Czech Republic
Corporate Office
- Carolina Centrum
- Drnovska 1112/60, Prague 6
- Prague, Ruzyně 161 00
- Czech Republic
Elphogene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Dec-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 10-Jun-2019 | Completed | Generating Revenue |
Elphogene Signals
Elphogene FAQs
-
When was Elphogene founded?
Elphogene was founded in 2019.
-
Where is Elphogene headquartered?
Elphogene is headquartered in Prague, Czech Republic.
-
What is the size of Elphogene?
Elphogene has 6 total employees.
-
What industry is Elphogene in?
Elphogene’s primary industry is Monitoring Equipment.
-
Is Elphogene a private or public company?
Elphogene is a Private company.
-
What is Elphogene’s current revenue?
The current revenue for Elphogene is .
-
How much funding has Elphogene raised over time?
Elphogene has raised $217K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process